- Benchmark ASINB0H3996FCF
- MarketplaceUS
- Category ID3762561
- Analyzed Products
- Keywordhome health product
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥8.14estimated
- Data Date2026-08-01
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不适合现在进入。 新品牌只有2个，表面成功率50%，但样本太小，而且唯一赚钱的只是 Easy@Home 这种强品牌；Identify Health 直接亏损并且没有起量，说明这里不是“普通小卖家也能试”的市场，而是已经偏向品牌和功能壁垒竞争。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing这不是适合现在进入的市场：样本里只有2个新品牌，但结果已经一半赚钱、一半亏钱，且没有任何老品牌案例可借鉴，说明这里更像是早期试水而不是成熟机会；真正能赚钱的只有 Easy@Home 的 B0H3996FCF，另一款 Identify Health 的 B0FXBM3TX3 已经是负利润且没起量，用户可以进，但必须按“高投入、强差异化”来做，普通小卖家不值得硬冲。
证据很直接：User budget 是 500000 CNY，但当前可见的盈利样本 B0H3996FCF 售价 $13.56，单品月销 400、月收入 $542,400，利润率 16.69%，属于能跑通的样本；但它的成功点是 品牌力 + 功能差异（10 mIU/mL 更早检出），不是低成本铺货。反过来，Identify Health 的 B0FXBM3TX3 售价 $7.46，利润率 -3.9%，29 条评价 仍然没转正，说明低价并不能解决这个市场的成本压力。按你要求的标准，这种“多数利润低于15%就不算好机会”的场景里，目前能看到的只有 1 个正例、1 个反例，小卖家没有清晰的 genuine 成功路径；如果要做，至少要复制 Easy@Home 这种差异化路线，而不是走同质化低价路线。
结论很硬：大品牌有可能进，小卖家不适合盲目进；如果进，小卖家也需要接近“品牌化打法”，而不是常规铺货。大品牌应跟的 benchmark 是 Easy@Home / B0H3996FCF；小卖家目前没有可确认的低评论真成功案例可学，Identify Health / B0FXBM3TX3 只能当失败警示，不是案例。最关键的一点是：这个市场里已经出现“低价、同质、负利润”的样本，说明竞争不是在比谁更便宜，而是在比谁更强的品牌和功能壁垒。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):50.00%Which new brands have these successful new listings?Alternatives- 药店/超市自有品牌早孕试纸：通常更便宜、购买更方便，适合对品牌不敏感且只想做基础筛查的用户。
- 基础款尿液早孕试纸条（非“超早测”版本）：价格更低，灵敏度虽不如高敏款，但对已到月经推迟后的常规检测足够使用。
- 多次装的经济型试纸套装：单次成本更低，适合需要反复复测、预算敏感或想降低一次性购买成本的用户。
- 线上订阅/批量补货的标准早孕试纸：通过批量采购摊薄单次成本，比购买单盒超早测更有价格优势。
- 验孕笔/一体式基础验孕产品：使用方式更直观，减少操作步骤，对不想接触试纸条和尿杯的用户更友好。
- 家庭基础生育监测组合包中的常规验孕模块：如果用户本来就会买排卵/孕酮监测相关产品，顺带使用套装中的基础验孕功能可替代单独购买高敏早孕试纸。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，已经呈现出明显的价格战风险，而且小品牌几乎没有真实成功样本。 目前能看到的结果是：新品牌里只有 Easy@Home 这种强品牌做出了成功新品，普通新品牌 Identify Health 则直接亏损并且没跑出销量；对大品牌是“能打但要重投”，对小企业是“不建议进”。
证据很直接：Easy@Home 的新品 B0H3996FCF 售价 13.56 美元，利润率 16.7%，月销 400、月收入 5,424 美元，上市仅 16 条评价却能保持 4.9 分，早期投入约 12,465 美元，其中广告就占 3,191 美元。它靠的是品牌力 + 功能差异化：10 mIU/mL 高灵敏度、粉白女性护理视觉、细长试纸形态。 这类打法说明大品牌要进来不是没机会，但要准备重投入，而且还得做出明显功能差异和品牌心智；预算 50 万元人民币对单个 ASIN 来说够启动，但远远不够保证长期品牌建设和持续投放。
反面样本更能说明问题：Identify Health 的 B0FXBM3TX3 售价 7.46 美元，利润率 -3.9%，29 条评价、4.7 分，却没有销量和收入，属于直接失速的新品牌新品。 市场里新品牌新品的盈利率只有 50%，另一半是亏损；最近一年可见的新品牌新品也就是这两个样本，没有出现你要求的那种“<300 评价就真实成功”的小企业案例。结合月度趋势看，2025 年 10 月出现亏损新品，2026 年 6 月才出现一个盈利新品，说明不是稳定扩张，而是少数强者偶发胜出。结论很清楚：大品牌可参考 Easy@Home 去做高灵敏度、差异化包装和足够广告预算；小企业不要把 Identify Health 这种失败新品当模板，更不要用低价硬拼。
New products with Highest revenueEasy@Home
Recent Monthly Revenue (USD):$5,424.00(400pcs/month)B0H3996FCF (4.9/5 (16 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableMost investment in new productsLeast investment in new productsLeast profitable new productsIdentify Health
Recent Monthly Revenue (USD):-(-)B0FXBM3TX3 (4.7/5 (29 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0H3996FCF (4.9/5 (16 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0FXBM3TX3 (4.7/5 (29 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入，至少按当前数据看是明显的高风险市场，不适合现在下场。 现有样本里只有2个可判断利润率的新品/产品，盈利与亏损各占50%，但真正能赚钱的只有 Easy@Home 的 B0H3996FCF，利润率 16.69%，月销 400、月营收约 54.24 万美元；另一个 Identify Health 的 B0FXBM3TX3 价格 $7.46，利润率 -3.9%，且没有有效销量，说明低价位段已经被成本吞没。 对大品牌来说，能参考的只有 Easy@Home 这种已经验证过的新品，说明它依靠的是更强品牌力和更好的定价/转化，而不是普遍可复制的高利润空间；对小品牌来说，当前没有任何“真小品牌”成功样本，Identify Health 这个新进者直接亏损，且 29 条评论在不到 1 年内就出现，具备明显的强推痕迹，但仍然没跑通。 结论很直接：这不是一个适合小品牌自然切入的市场，也不是一个适合大规模强行进入的舒适市场；如果硬要做，至少要按 Easy@Home 的打法准备更高的品牌和投放成本，否则很容易掉进 10% 以下利润率的价格战里。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0H3996FCFEasy@Home2026-06-24Yes$13.56400pcs$5424.016.69%$905.27Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0H3996FCFEasy@Home2026-06-24Yes$13.56400pcs$5424.016.69%$905.27#New Product Success Rates
Listing这个市场不值得进入，结论是偏高壁垒且对新卖家不友好。 目前可见的新品牌成功非常少，且成功主要被 Easy@Home 这种强势玩家拿走；更关键的是，近期开新产品的样本里，赚钱和亏钱各占一半，说明不是“有机会但难”，而是已经进入了强竞争区。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
Easy@HomeNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Identify Health#Success Rate by Entry Time
Listing这个市场不值得进入，结论很明确：新品牌几乎没有跑通，且最近的成功只来自单一品牌，市场更像是高门槛、低容错的筛选场，而不是可复制的机会。 当前可见样本里，新品牌新上架只有2个，成功率50%，但这只是极小样本；更关键的是，失败占比同样是50%，而且最近两年的新增记录里，2025年只有 Identify Health 的 B0FXBM3TX3 失败，2026年才出现 Easy@Home 的 B0H3996FCF 成功，说明入场结果完全不稳定，不能视为“容易赚钱”的市场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 1 2026 0 0 0 1 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 1 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 1 0 0 0 0 2026/7 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesEasy@HomeB0H3996FCF (4.9/5 (16 Reviews))easy@Home Early Pregnancy Tests: 6 Days Before Missed Period*
This listing is deemed profitablePrice (USD)$13.56Released TypeNew Release (2026-06-24)Brand is a new entry in this marketSize and Weight18.5 x 10.1 x 3.3 cm, 118.00gProfitable Factors
Established brand with longevityDistinct functions and featuresDesign & Appearance
粉白配色，强化“早孕/女性护理”感知, 细长试纸外形，强调便携和即时检测Key Buying Motive
10 mIU/mL高灵敏度，主打比常规25 mIU/mL更早检出Target Customers
备孕人群、需要在月经推迟前尽早确认结果的用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$5,424.00400 sold in the past 30 days · as of 2026年8月Net Profit Margin
Sea Freight14.00% / 16.69%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight9.75% / 12.45%Peak / Non PeakSales & BSR Performance